Skip to main content

Table 1 Descriptions of studies based on sample populations and stimulation parameters

From: Strategies to implement and monitor in-home transcranial electrical stimulation in neurological and psychiatric patient populations: a systematic review

Study

Study Design and Population

Stimulation Parameters

 

Design

Size

Gender

Age (years)

Condition

Type

Target Area

Electrodes

Current

Session

Duration

Andrade 2013

Case series

1

1F

25

Schizophrenia

Zeebeetronics

F3 (Anodal tDCS)

25cm2

1–3 mA

3 years

20–30 min

Andre 2016

RCT

22

NS

63–94

Dementia

NeuroConn

DLPFC (Anodal tDCS)

35cm2

2 mA

4 sessions

20 min

Carvalho 2018

Case series

1

1F

57

Neuropathic pain

Neuroelectric Starstim

M1 (Anodal tDCS)

35cm2

2 mA

5 sessions

20 min

Cha 2016

RCT

24

24F

52.9 ± 12.2

MdDS

Transcranial Technologies

DLPFC

35cm2

1 mA

20 sessions

20 min

Charvet 2017a

Observational

25

21F, 4 M

51.0 ± 12.7

MS

Soterix Mini-Clinical Trials

DLPFC (Anodal tDCS)

35 cm2

1.5 mA

10 sessions

20 min

Charvet 2017b1

RCT

27

16F, 11 M

44.2

MS

Soterix Mini-Clinical Trials

DLPFC (Anodal tDCS)

25 cm2

2 mA

20 sessions

20 min

Clayton 2018

Case series

1

1F

54

MS, Bipolar

NS

DLPFC (Anodal tDCS)

NS

2 mA

40 sessions

20 min

Dobbs 2018

Case series

16

4F, 12 M

66.9 ± 5.4

PD

Soterix Mini-Clinical Trials

DLPFC (Anodal tDCS)

25cm2

2 mA

10 sessions

20 min

Hagenacker 2014

RCT - crossover

17

10F, 7 M

32–82

Trigeminal neuralgia

Neuronica

M1 (Anodal tDCS)

16cm2

1 mA

14 sessions

20 min

Hyvarinen 2016

Observational

43

20F, 23 M

51 ± 15.4

Tinnitus

Sooma

Auditory or bifrontal tDCS

35cm2

2 mA

10 sessions

20 min

Kasschau 2016

Case series

20

17F, 3 M

30–69

MS

tDCS mini-Clinical Trial

DLPFC

25cm2

1.5 mA

10 sessions

20 min

Loo 2017

Case series

10

NS

NS

Depression

NS

DLPFC

NS

2 mA

20 sessions

30 min

Martens 2018

RCT - crossover

27

8F,19M

42 ± 14.5

MCS

CEFALY tDCS

DLPFC

35cm2

2 mA

20 sessions

20 min

Mortenson 2016

RCT

16

7F, 9 M

44–76

Stroke

NeuroConn

M1 (Anodal tDCS)

35cm2

1.5 mA

5 sessions

20 min

Riggs 2018

Case series

4

2F, 2 M

44–63

Multiple conditions

Soterix Mini-Clinical Trials

DLPFC/M1 (Anodal tDCS)

25cm2

1–1.5 mA

10 sessions

20 min

Schwippel 2017

Case series

1

1 M

31

Hallucinations

Neuroconn

Tempoproparietal (Anodal tDCS)

35cm2

2 mA

400 sessions

20 min

Sharma 2018

RCT

12

NS

64.7 ± 7.1

PD

NS

DLPFC

NS

2 mA

10 sessions

20 min

Treister 2015

Case series

11

7F, 4 M

60.6 ± 16.3

Neurological pain

NS

M1 (Anodal tDCS)

NS

1.5 mA

12 sessions

20 min

Van de Winckel 2018

Case series

6

3F, 3 M

61 ± 10

Stroke

StartSim

M1 bihemispheric

20cm2

1.5 mA

5 sessions

20 min

  1. DLPFC = Dorsolateral prefrontal cortex; F = female; M = male; MCS = Minimally conscious state; MdDS = Mal De Debarquement Syndrome; MS = Multiple sclerosis; M1 = primary motor cortex; NS = not stated; PD = Parkinson’s disease; RCT = Randomised controlled trial; tDCS = transcranial Direct Current Stimulation
  2. 1, data only reported for study two